1-3 of 3
Masami Kaji
Close
Sort by
Journal Articles

Tumor Antigen Small Guide (sg) RNA as a Completely Unique Nucleic Acid Medicine for Leukemia and Other Tumors.

Norihiro Watanabe, Miwako Narita, MD, Akie Yamahira, Nozomi Tochiki, Takeshi Nakamura, Anri Saitoh, Masami Kaji, Tomoyo Taniguchi, Tatsuo Furukawa, MD, Yoshifusa Aizawa, MD, Masayuki Nashimoto, Masuhiro Takahashi, MD
Journal: Blood
Blood (2009) 114 (22): 2461.
https://doi.org/10.1182/blood.V114.22.2461.2461
Published: 2009
Journal Articles

Effectiveness of WT1 Peptide Vaccination Combined with Imatinib in a Patient with CML in Chronic Phase.

Anri Saitoh, Miwako Narita, MD, Akie Yamahira, Takeshi Nakamura, Nozomi Tochiki, Norihiro Watanabe, Masami Kaji, Tomoyo Taniguchi, Masayoshi Masuko, MD, Tatsuo Furukawa, MD, Ken Toba, MD, Ichiro Fuse, MD, Yoshifusa Aizawa, MD, Masuhiro Takahashi, MD
Journal: Blood
Blood (2009) 114 (22): 4253.
https://doi.org/10.1182/blood.V114.22.4253.4253
Published: 2009
Journal Articles

A Unique Immunotherapeutic Atrategy by Using a Leukemic Plasmacytoid Dendritic Cell Line (PMDC05) as Potent Antigen Presenting Cells.

Takeshi Nakamura, Miwako Narita, MD, Akie Yamahira, Norihiro Watanabe, Nozomi Tochiki, Anri Saitoh, Masami Kaji, Tomoyo Taniguchi, Shigeo Hashimoto, MD, Tatsuo Furukawa, MD, Ken Toba, MD, Ichiro Fuse, MD, Yoshifusa Aizawa, MD, Masuhiro Takahashi, MD
Journal: Blood
Blood (2009) 114 (22): 5117.
https://doi.org/10.1182/blood.V114.22.5117.5117
Published: 2009